ESYT2 Knockout HEK293 Cell Line
Cat.No.:
EDC07553
Species:
Human
Cell Name:
HEK293
Gene:
ESYT2
Gene ID:
57488
Size:
1×10⁶cells
ESYT2 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07553 |
|---|---|
| Product Name | ESYT2 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | ESYT2 |
| NCBI Gene ID | |
| Gene Synonyms | CHR2SYT|E-Syt2|FAM62B |
| Summary |
Enables calcium ion binding activity; identical protein binding activity; and phospholipid binding activity. Predicted to be involved in endocytosis; endoplasmic reticulum-plasma membrane tethering; and lipid transport. Located in several cellular components, including cytoplasmic side of plasma membrane; endoplasmic reticulum membrane; and endoplasmic reticulum-plasma membrane contact site. [provided by Alliance of Genome Resources, Jul 2025]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying ESYT2 function, ESYT2 Knockout HEK293 Cell Line or ESYT2 overexpression HEK293 Cell Line?
The choice depends on whether you are studying ESYT2's role as an ER-PM contact site tether or its functions in non-vesicular lipid transfer and calcium-regulated signaling. The Knockout line is the standard tool for asking whether ESYT2 is required for these processes — ESYT2 has been the most-characterized ESYT family member, mediating phospholipid transfer at ER-PM junctions and showing calcium-regulated tethering. Overexpression is useful for studying ESYT2 gain-of-function effects.
Important consideration: ESYT1, ESYT3 paralog expression analysis aids interpretation given functional overlap. This product complements the parallel ESYT3 Knockout and the ESYT2 & ESYT3 Double Knockout in HEK293 (both also available) for paralog-specific functional dissection. Rescue with wild-type, SMP-domain-mutant (lipid-transfer-deficient), or C2-domain-mutant (PM-binding-deficient) ESYT2 enables structure-function studies.
What are the application scenarios for this model?
Primary applications:
• Calcium-regulated ER-PM tethering: ESYT2 calcium-regulated PM binding analysis through C2 domains.
• Non-vesicular lipid transfer: glycerophospholipid transport quantification at ER-PM junctions.
• PI(4,5)P2 dynamics: PIP2 replenishment at PM following stimulus-induced depletion.
• Cross-paralog analysis: combined analysis with ESYT3 KO and ESYT2&ESYT3 Double KO for systematic ESYT family dissection.
EDITGENE recommends this model for researchers investigating ESYT2 biology and ER-PM contact site lipid transfer.
Is this ESYT2 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. ESYT2 rescue experiments require attention to ER-PM contact site architecture:
• Construct design: use a codon-modified ESYT2 sequence with a small C-terminal tag (FLAG, HA). ESYT2 has the canonical ESYT architecture (ER hairpin, SMP domain, multiple C2 domains) — preserve all elements.
• Calcium-binding-deficient rescue: C2 domain Ca²⁺-binding aspartate mutations affect calcium-regulated tethering.
• Functional readout: rescue should restore ER-PM contact site formation and calcium-regulated lipid transfer.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Related Publications
Multiple cAMP/PKA complexes at the STIM1 ER/PM junction specified by E-Syt1 and E-Syt2 reciprocally gates ANO1 (TMEM16A) via Ca.
IF=15.7
Nature communications
ANO1 plays a crucial role in determining numerous physiological functions, including epithelial secretion, yet its regulatory mechanisms remain incompletely understood. Here, we describe a fundamental dynamic regulation of ANO1 surface expression and Ca-dependent gating via the cAMP/PKA pathway at the STIM1 ER/PM junctions. At these junctions, STIM1 assembles AC-AKAP-PKA complexes, while E-Syt1 mediates formation of ANO1-VAPA-IRBIT-E-Syt1-AC8-AKAP5-PKA complex, that phosphorylates ANO1 S673, increasing ANO1 Ca affinity. Within these complexes, the Ca and cAMP pathways act synergistically to enhance ANO1 function. By contrast, E-Syt2 dissociates the ANO1-VAPA interaction, forming ANO1-IRBIT-E-Syt2-AC6-AKAP11-PKA complex that phosphorylates ANO1 S221, which markedly reduces ANO1 Ca affinity. The effects of the E-Syts are primarily mediated by their reciprocal regulation of junctional PI(4)P, PI(4,5)P and PtdSer. Accordingly, IRBIT deletion in mice impairs receptor-stimulated activation of ANO1 and fluid secretion. These findings should have broad implications for ANO1 roles and functions across various tissues.
This KO model may be useful for:
- Investigating the role of E-Syt2 in organizing cAMP/PKA signaling complexes at ER/PM junctions
- Studying the regulation of Ca²⁺-dependent ion channels, specifically ANO1 (TMEM16A), by E-Syt-mediated membrane contact sites
- Elucidating the reciprocal gating mechanisms between STIM1, E-Syt proteins, and ion channel activity
- Functional dissection of E-Syt1 vs. E-Syt2 specificity in junctional signaling and calcium homeostasis
- Exploring the interplay between lipid transfer and ion channel modulation at ER-plasma membrane contact sites
download